← GODS Home
Astragalus
Ingredient · 5 compounds · 2 conditions

Astragalus is profiled across the CytoSolve® knowledge base and mapped to the disease biology it influences — tracing each of its compounds through disease, biological process, molecular pathway and down to individual biomarkers, with source videos and references at each step.

Compare
Add ingredients to compare side-by-side

Comparison

All Compound Disease Biological Process Molecular Pathway
Compound · 2 disease(s) · 5 pathway(s)
Disease · 2 process(es) · 2 pathway(s)
Fibrosis1 pathway
TGF-β Signaling
◈ TargetTGF-β
E-cadherin, Vimentin, α-SMA
Mucus Hypersecretion1 pathway
CHOP/MUC5AC Signaling
◈ TargetER stress/CHOP
Mucin 5, CHOP
Disease · 2 process(es) · 3 pathway(s)
Apoptosis1 pathway
Fas/FasL Signaling
◈ TargetPro-caspase-8 cleavage
BCL-2, BAX, Capase-3, Caspase-9
Cell Proliferation2 pathways
Fas/FasL Signaling
◈ TargetFas/FasL
Fas/FasL
Wnt Signaling
◈ TargetTNF-α
TGF-α, β-catenin
Compound · 1 disease(s) · 1 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Fibrosis1 pathway
TGF-β Signaling
◈ TargetTGF-β
E-cadherin, Vimentin, α-SMA
Compound · 1 disease(s) · 1 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
NRF2/Keap Signaling
◈ TargetNrf2
SOD, CAT
Compound · 1 disease(s) · 1 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Mucus Hypersecretion1 pathway
PKC/EGFR/ERK Signaling
◈ TargetPKC
PKC, Mucin-5
Compound · 1 disease(s) · 1 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Mucus Hypersecretion1 pathway
IL-13 Signaling
◈ TargetIL-13
IL-13, Mucin-5